The enhanced β-catenin protein levels and phosphorylation of GSK3β suggest that ERα36 plays roles in the activation of canonical Wnt signaling, which has been widely linked to tumor progression and multidrug resistance. This evidence concerns the gene GSK3B and neoplasm.